These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 4196346)
1. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs. Beyer J; Haupt E; Cordes U; Kutschera J; Schöffling K Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346 [No Abstract] [Full Text] [Related]
2. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)]. Loubatières A; Ribes G; Mariani MM; Alric R Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420 [No Abstract] [Full Text] [Related]
4. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea]. Beyer J; Cordes U; Sell G; Schöffling K Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965 [No Abstract] [Full Text] [Related]
5. [Insulin liberation by blood sugar decreasing sulfonamides and by glucose in adult diabetic patients]. Haupt E; Köberich W; Rosak C; Beyer J; Schöffling K Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2198. PubMed ID: 4198967 [No Abstract] [Full Text] [Related]
6. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide). Loubatiéres A; Mariani MM; Ribes G; Alric R Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675 [No Abstract] [Full Text] [Related]
7. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro]. Beyer J; Gather W; Schöffling K Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966 [No Abstract] [Full Text] [Related]
8. [Current concepts of the pancreatic and extrapancreatic mechanisms of the action of peroral hypoglycemic sulfonylurea preparations]. Poltorak VV; Gladkikh AI Probl Endokrinol (Mosk); 1985; 31(2):76-85. PubMed ID: 2859589 [No Abstract] [Full Text] [Related]
9. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)]. Haupt E; Beyer J; Schöffling K Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186 [No Abstract] [Full Text] [Related]
10. [Secretion of insulin under the influence of sulfonylurea derivates (SH)]. Rothenbuchner G; Raptis S; Pfeiffer EF Wien Z Inn Med; 1973; 54(2):69-77. PubMed ID: 4203274 [No Abstract] [Full Text] [Related]
11. [Effect of glycemia level on insulin secretion caused by an hypoglycemic sulfamide (glisoxepide) in dogs]. Loubatières AL; Ribes G; Loubatières-Mariani MM C R Seances Soc Biol Fil; 1972; 166(8):1047-50. PubMed ID: 4573746 [No Abstract] [Full Text] [Related]
12. Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents? Marble A Drugs; 1971; 1(2):109-15. PubMed ID: 4999930 [No Abstract] [Full Text] [Related]
13. [Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas]. Beyer J; Haupt E; Cordes U; Sell G; Schöffling K Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1668-75. PubMed ID: 4205544 [No Abstract] [Full Text] [Related]
14. [Extrapancreatic effects of sulfonylurea compounds. I. Studies on the effect of tolbutamide and glibornuride on blood sugar, nonesterified fatty acids, glycerin, lactate and pyruvate in the pancreatectomized dog chronically treated with insulin]. Beyer J; Cordes U; Krall H; Sell G; Schöffling K Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2167. PubMed ID: 4679246 [No Abstract] [Full Text] [Related]
15. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics]. Haupt E; Beyer J; Schöffling K Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557 [No Abstract] [Full Text] [Related]
16. [Extrapancreatic effects of sulfonylurea compounds. II. Comparison of equimolar concentrations of tolbutamide, glibornuride, hydroxymethyltolbutamide, carboxytolbutamide, and carboxyglycylamide with reference to their blood-sugar-decreasing and antilipolytic effect on completely pancreatectomized dogs, chronically treated insulin]. Beyer J; Cordes U; Sell G; Krall H; Schöffling K Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2172. PubMed ID: 4679247 [No Abstract] [Full Text] [Related]
17. [Comparative use of gliquidone and tolbutamide administered intravenously]. Zilker T; Lüders L; Bottermann P MMW Munch Med Wochenschr; 1975 Sep; 117(36):1421-2. PubMed ID: 126376 [No Abstract] [Full Text] [Related]
18. [Insulin secretion following combined administration of glucose and different sulfonylurea compounds in equipotential doses in metabolically healthy persons]. Happ J; Beyer J; Jungmann E; Scherer U; Haupt E; Schöffling K Verh Dtsch Ges Inn Med; 1973; 79():1213-6. PubMed ID: 4208215 [No Abstract] [Full Text] [Related]
19. [Effect of a new sulfonylurea on insulin and glucagon secretion in the isolated perfused pancreas]. Laube H; Fussgänger RD; Schröder KE; Pfeiffer EF Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2186. PubMed ID: 4579624 [No Abstract] [Full Text] [Related]
20. Insulinotropic action of a new sulfonylurea: gliclazide. Malaisse WJ; Leclercq-Meyer V Rev Eur Etud Clin Biol; 1972 Mar; 17(3):310-4. PubMed ID: 4626523 [No Abstract] [Full Text] [Related] [Next] [New Search]